12 completed. 12 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 12 | Completed 12 |
| Phase 2 | 4 | Completed 4 |
Follow Reverse Transcriptase Polymerase Chain Reaction: new trials by email Literature Review of Reverse Transcriptase Polymerase Chain Reaction trials Research Report on Reverse Transcriptase Polymerase Chain Reaction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer letrozole, panobinostat, RNA analysis - Breast Cancer | Phase 1 / Phase 2 | Completed | Alliance for Clinical Trials in Oncology | 28 | 2010-09-01 | 2017-06-27 |
| Low-Dose Azacitidine, Lenalidomide, and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma azacitidine, lenalidomide, dexamethasone - Refractory Multiple Myeloma | Phase 1 / Phase 2 | Completed | Case Comprehensive Cancer Center | 45 | 2010-06-01 | 2020-11-16 |
| 5-Fluoro-2'-Deoxycytidine and Tetrahydrouridine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes 5-fluoro-2-deoxycytidine, tetrahydrouridine, laboratory biomarker analysis - Adult Acute Myeloid Leukemia, de Novo Myelodysplastic Syndromes | Phase 1 | Completed | City of Hope Medical Center | 25 | 2009-12-22 | 2026-10-16 |
| Decitabine, Vaccine Therapy, and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer decitabine, NY-ESO-1 peptide vaccine, pegylated liposomal doxorubicin hydrochloride - Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer | Phase 1 | Completed | Roswell Park Cancer Institute | 18 | 2009-04-01 | 2022-08-01 |
| Dasatinib and Vorinostat in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia dasatinib, vorinostat, cytogenetic analysis - Leukemia | Phase 1 | Completed | City of Hope Medical Center | 5 | 2008-09-01 | 2012-07-17 |
| Fusion Protein Cytokine Therapy After Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma DI-Leu16-IL2 immunocytokine, rituximab, flow cytometry - Anaplastic Large Cell Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma | Phase 1 | Completed | City of Hope Medical Center | 9 | 2008-03-17 | 2026-10-23 |
| Clofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Myelodysplastic Syndromes clofarabine, melphalan, gene expression analysis - Leukemia, Myelodysplastic Syndromes | Phase 1 | Completed | City of Hope Medical Center | 20 | 2007-07-27 | 2026-10-19 |
| Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx carboplatin, cisplatin, docetaxel - Head and Neck Cancer | Phase 1 / Phase 2 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 7 | 2007-05-01 | 2018-07-09 |
| AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors AEG35156, docetaxel, protein expression analysis - Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Completed | NCIC Clinical Trials Group | 27 | 2006-07-27 | 2023-08-04 |
| Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors lapatinib ditosylate, vinorelbine ditartrate, comparative genomic hybridization - Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Completed | University of California, Davis | 22 | 2005-12-01 | 2012-04-19 |
| Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors bortezomib, pemetrexed disodium, gene expression analysis - Lung Cancer, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 / Phase 2 | Completed | University of California, Davis | 27 | 2005-03-01 | 2018-10-31 |
| Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer carcinoembryonic antigen-expressing measles virus, oncolytic measles virus encoding thyroidal sodium iodide symporter, reverse transcriptase-polymerase chain reaction - Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 1 | Completed | Mayo Clinic | 37 | 2004-04-19 | 2024-01-16 |
Carcinoma, Ovarian Epithelial (2) · Leukemia (2) · Leukemia, Myeloid, Acute (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Blast Crisis (1) · Breast Neoplasms (1) · Breast Neoplasms, Male (1) · Brenner Tumor (1) · Carcinoma, Non-Small-Cell Lung (1) · Congenital Abnormalities (1) · Fallopian Tube Neoplasms (1) · Head and Neck Neoplasms (1) · Intraocular Lymphoma (1) · Leukemia, Myeloid, Accelerated Phase (1) · Lung Neoplasms (1)
City of Hope Medical Center (4) · University of California, Davis (2) · Alliance for Clinical Trials in Oncology (1) · Case Comprehensive Cancer Center (1) · European Organisation for Research and Treatment of Cancer - EORTC (1) · Mayo Clinic (1) · NCIC Clinical Trials Group (1) · Roswell Park Cancer Institute (1)
United States (10) · Belgium (1) · Canada (1)
Ahmad Awada, MD, PhD (1) · Angela Davies, MD (1) · Anthony Stein, MD (1) · David Snyder, MD (1) · Ehsan Malek, MD (1) · Evanthia Galanis, MD (1) · Frederic Reu (1) · Gerald Batist, MD (1) · Helen K. Chew, MD (1) · Kunle Odunsi (1) · Robert Chen, MD (1) · Ryotaro Nakamura (1) · Winston Tan, MD, FACP (1)
PMID 18090584, PMID 22989664, PMID 26774555
P30CA033572 (2), P30CA015083 (1), P30CA093373 (1), P50CA107399 (1), P50CA136393 (1)